Moving Medicine Forward

• CTI Year in Review: Resilience, Innovation, & What’s Next

  In this special year-end episode of Moving Medicine Forward, host Jeremy Schrand sits down with CTI’s founder and CEO Tim Schroeder and President & COO Jon Koch for an in-depth look at 2025. From strategic goals and operational breakthroughs to cultural pillars and global challenges, Tim and John share candid insights on what made this year transformative for CTI. They also discuss major clinical milestones, regulatory shifts, and the innovations shaping the future—including AI, patient-centric trial design, and advanced therapies. Whether you’re a team member, sponsor, or industry partner, this conversation offers a front-row seat to the trends and strategies driving the next era of clinical research. 00:36 Tim Schroeder and John Cook join for a candiddiscussion on CTI’s journey through 2025. 01:00 Strategic goals, clinical milestones, andcultural highlights that defined the year. 01:39 Tim reflects on CTI’s long-term vision, processimprovements, and technology adoption. 02:58 Balancing analytics-driven growth with personaland professional development. 04:00 John shares key initiatives—integratingclinical, site, and lab capabilities; EMA’s adoption of ICH E6(R3). 05:33 Nearly 20 successful approvals over two yearsunderscore CTI’s mission. 06:08 Navigating new clients, acquisitions, andglobal disruptions while maintaining quality. 07:17 How CTI adapted to FDA leadership changes andglobal health trends. 11:38 Care, persistence, and community engagement asdefining traits of CTI’s global team. 14:34 Persistence and stability in an industry withhigh stakes and long timelines. 17:08 Priorities include ICH E6(R3) implementation,global expansion, and AI-driven innovation. 20:22 Building the strongest management team forCTI’s next quarter-century. 22:03 Tim and John share messages of thanks andconfidence in the future of medicine. 25:15 CTI’s commitment to advancing medicine andfostering a culture of care and resilience.

  --------  

  26:13

  --------

  26:13
• Turning Complexity into Progress: Hematology’s Path Forward

  Courtney Cordaro, Director and Therapeutic Strategy & Innovation Lead at CTI, discusses the rapidly changing landscape of hematology clinical research. She shares insights on operational excellence and innovation, demonstrating why adaptability and precision are key to success in hematology clinical trials. 01:00 Courtney shares her background and passions. 02:29 The growing need for rapid innovation in hematology trials. 03:57 Unique challenges in hematology trials. 05:17 The evolving role of project management. 08:28 Strategies for maintaining compliance and data integrity. 10:46 Differentiators in CTI’s hematology research.  13:54 Future trends within the field. 15:19 The five pillars of success. 18:01 Advice for sponsors entering this space. 

  --------  

  20:39

  --------

  20:39
• Building Strong Site-CRO Partnerships: Insights from ASN 2025

  Recorded live at American Society of Nephrology’s Kidney Week 2025, this episode of Moving Medicine Forward features Courtney Cordaro, Director of Therapeutic Strategy at CTI, and Morgan Terry, Site Director at Eastern Nephrology Associates. Together, they discuss what drives a healthy and productive partnership between clinical research sites and CROs, the critical role of communication, and how both sides can adapt to the evolving landscape of nephrology trials.  01:31 What defines a strong site-CRO relationship 01:49 Key elements of a successful partnership 02:32 The importance of consistency and communication in nephrology research 03:33 How CRO staff changes affect timelines and site efficiency 04:09 Common misconceptions CROs have about sites 05:23 Behaviors and practices that show a CRO’s understanding and build trust 06:31 How an effective CRO response can shape stronger partnerships 07:35 Why minimal turnover and familiarity with site processes are key to building long-term trust 09:05 Adapting to decentralized trials by leveraging strategies for remote monitoring and precision medicine 10:37 Highlighting collaboration and adaptability as keys to success 

  --------  

  11:36

  --------

  11:36
• The Science of Compassion: Advancing Oncology Trials

  In this inspiring episode of Moving Medicine Forward,Amanda King, Senior Clinical Scientist at CTI, discusses her remarkable journey from pediatric ICU nurse practitioner to leading-edge oncology researcher. Amanda shares how personal loss fueled her passion for patient-centered careand clinical research, and how her work at the NIH and CTI is shaping the future of medicine. From the complexities of oncology trials to the emotional weight of working with vulnerable patients, Amanda offers a candid look at thechallenges and triumphs of advancing therapeutic options. Whether you're in healthcare or simply curious about the human stories behind medical innovation, this episode is a must-listen.00:30 Meet Amanda King: her background and passionfor patient-centered care. 01:07 Amanda’s clinical roots in pediatric ICU andtransition to research. 02:00 Pursuing a PhD and discovering a love forclinical trials at the NIH. 02:34 The motivation behind Amanda’s shift toclinical research. 03:34 Why Amanda joined CTI and what drew her toindustry research. 05:10 Amanda’s role as a Senior Clinical Scientistand her impact on trial safety. 06:35 Deep dive into Amanda’s work at the NIH and theimportance of patient outcomes data. 09:21 Challenges in oncology trials: balancingsafety, complexity, and emotional toll. 11:39 The rewards of working in oncology and Amanda’spersonal connection to cancer research. 13:08 Advice for young people interested in clinicalresearch and the importance of mentorship. 15:14 Amanda’s vision for the future of medicine:innovation meets compassion. 16:10 Closing thoughts and how to stay connected withCTI.

  --------  

  16:48

  --------

  16:48
• What Makes a Great CRO: Insights with Joel White

  Joel White, Owner of Marketcap Consulting, joins another episode to discuss the evolving role of Clinical Research Organizations (CROs). He shares the characteristics of a great CRO, how technology and decentralization are shaping the industry, and the strategic balance between speed, quality, and cost in clinical trials. Whether you're a sponsor, CRO professional, or simply curious about the clinical trial landscape, this episode offers practical wisdom and forward-looking perspectives on drug development and innovation.  00:31 Joel White returns to explore CRO excellence and innovation  01:00 Joel’s background and journey into the CRO industry  01:55 Origins of Joel’s LinkedIn quarterly recaps and their impact  04:10 Defining CROs and their evolving role in clinical trials  05:48 What separates great CROs from average ones, such as customer service and repeat business  08:59 Technology’s role in CRO operations and vendor management  11:29 Balancing speed, quality, and cost in fast-paced trials  12:45 The importance of culture and leadership in CRO success  13:57 Common misconceptions sponsors have about CROs  16:45 Decentralization in clinical trials, including adoption trends and cost tradeoffs  19:05 Evaluating therapeutic area expertise when selecting a CRO  20:46 The future of CROs, consisting of innovation, partnerships, and the potential impact of AI

  --------  

  24:49

  --------

  24:49

Más podcasts de Ciencias

Podcasts a la moda de Ciencias

Acerca de Moving Medicine Forward